Publication | Open Access

Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies

Protease InhibitorsBiochemistryMedicinePharmacologyAntiviral Drug DevelopmentRational Drug DesignBiological EvaluationDrug DevelopmentMolecular DockingNovel P3 ScaffoldsDrug Discovery